PRAX Stock Analysis: Buy, Sell, or Hold?
PRAX - Praxis Precision Medicines, Inc. Common Stock
$305.37
1.98 (0.65%)
▲
5d:
+15.43%
30d:
-12.89%
90d:
+3.83%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When PRAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: PRAX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: PRAX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: PRAX is currently trading at $305.37, which is considered fair relative to its 30-day fair value range of $257.88 to $338.77.
Technical Outlook: Technically, PRAX is in a downtrend. The price is approaching resistance at $307.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (8th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $617.67 (+102.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PRAX is in a downtrend. The price is approaching resistance at $307.65. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRAX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (8th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $617.67 (+102.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$257.88 -
$338.77
Company Quality Score
59/100
(HOLD)
Options IV Signal
8th percentile
(COMPLACENCY WARNING)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 8th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 102.3% below Wall St target ($617.67)
Trading Range Analysis
30-Day Trading Range
$257.88 -
$338.77
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$27.66
(9.1%)
Support & Resistance Levels
Support Level
$238.77
Resistance Level
$307.65
Current Trend
Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.13
Wall Street Target
$617.67
(+102.3%)
Revenue Growth (YoY)
1349.1%
Share & Embed Analysis
Last updated: June 23, 2026 5:09 PM ET
Data refreshes hourly during market hours. Next update: 6:09 PM
Data refreshes hourly during market hours. Next update: 6:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 57 HOLD |
Advanced PRAX Option Strategies
Professional options setups generated by AI based on today's PRAX price and gamma walls.
